Charts Emmaus Life Sciences, Inc.

Stocks

Market Closed - OTC Markets 09:52:56 2026-06-01 EDT			5-day change	1st Jan Change
0.009600 ^USD	-4.00%		-83.32%	-26.15%

08-31	Emmaus Life Sciences Enters Exclusive Option Agreement with Cedars-Sinai to Investigate L-Glutamine Oral Powder for Pancreatic Ductal Adenocarcinoma	CI
08-14	Emmaus Life Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI

ProRealTime Chart